Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases

Clinical trial NCT00910728 · COMPLETED

Trial details

NCT number: NCT00910728
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Myelofibrosis (PMF)Post-Polycythaemia Vera Essential Thrombocythaemia Myelofibrosis

Start date: 2009-05-01
Primary completion: 2012-03-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.